Three women researchers receive Damon Runyon Clinical Investigator Award
Click Here to Manage Email Alerts
Three women oncologist researchers at Dana Farber Cancer Institute have been named recipients of the Damon Runyon Cancer Research Foundation Clinical Investigator Award.
The award honors “outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians,” according to a press release.
Photos courtesy of Dana Farber Cancer Institute.
Lachelle D. Weeks, MD, PhD, instructor in the department of medicine at Harvard Medical School and a physician-scientist in the adult leukemia program at Dana-Farber Cancer Institute, will create computerized models to review images of blood cells of individuals with clonal hematopoiesis and predict risk for acute myeloid leukemia.
Erin M. Parry, MD, PhD, researcher in the department of medical oncology at Dana Farber Cancer Institute, will assess the underlying genetics of follicular lymphoma transformation to ultimately improve future recognition and diagnosis of transformation, as well as detect potential therapeutic targets.
Megan L. Insco, MD, PhD, instructor in the department of medicine at Harvard Medical School and a physician-scientist at Dana-Farber Cancer Institute, will focus on identifying compounds that target melanomas that fail to clean up their aberrant RNAs and will investigate how immune cells can be activated to attack melanoma cells that have high levels of aberrant RNAs.
The investigator award grants $600,000 to each awardee over 3 years, in addition to assistance with research costs, according to the release.
Click Here to Manage Email Alerts